Summary
Erik Gafni is a seasoned AI-first technology leader and entrepreneur based in San Francisco with over a decade of experience building and scaling ML-powered biotech and AI products. As Co-Founder and CTO at TypeSafe AI and a Co-Founder at a stealth startup, he is shaping the future of LLM training stacks and practical AI deployment. He previously co-founded Ravel Biotechnology, where he built multi-modal DL models on high-throughput sequencing, led a collaboration resulting in a Nature publication, and helped secure $9.5M in funding. Earlier in his career, he led ML-driven production pipelines at Invitae and contributed to open-source tools like the Cosmos workflow manager, while also guiding research at Harvard Medical School. He has led ventures and hands-on engineering across roles including CEO/Head of AI at Eventum.ai and Senior roles at Freenome and Invitae, blending research excellence with scalable software delivery. He earned a BS in Computer Science and Health Science from the University of Arizona and brings a rare mix of practical ML, bioinformatics, and startup leadership.
12 years of coding experience